Public compound-state evidence data

41 names.
2050 state routes.

One downloadable source map connecting compound identity, evidence lane, state-specific context, official pharmacy verification, supporting records, and the exact atlas section for every maintained row.

A source-routing atlas, not a fifty-state legal verdict.Each row preserves the research, clinical-pipeline, or medicine identity and points to the official state record. It does not certify a product, seller, shipment, prescription, compounding basis, medical use, or statewide availability.
What this dataset adds

Compound identity joined to the destination record.

Every row retains the exact question, bounded answer, primary identity source, state record, supporting official record, review date, and permanent atlas section.

01

Fifty state routes

The dataset covers every US state, from Texas and California to Alaska, Maine, Hawaii, and Wyoming.

02

41 identities

Research listings, investigational programs, and approved medicine records stay in separate evidence lanes even when search results place them together.

03

Every row can be audited

Open the human-readable atlas section, follow the official sources, or download the full release for analysis and citation.

Human-readable state maps

Open any of the 41 compound atlases.

Each atlas contains 50 substantive state answers, official state record links, local guide handoffs, and the common identity source.

01FDA-reviewed unapproved peptide identity

KPV by state

Compare KPV across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

02US research-market identity

BPC-157 by state

Compare BPC-157 across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

03US research-market identity

TB-500 by state

Compare TB-500 across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

04US research-market identity

GHK-Cu by state

Compare GHK-Cu across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

05US research-market identity

Semax by state

Compare Semax across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

06US research-market identity

Melanotan II by state

Compare Melanotan II across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

07US research-market identity

MOTS-c by state

Compare MOTS-c across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

08US research-market identity with a separate FDA-licensed medicine record

Tesamorelin by state

Compare Tesamorelin across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

09US research-market identity with a failed oral obesity program and no FDA-approved drug

AOD-9604 by state

Compare AOD-9604 across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

10US research-market identity

Ipamorelin by state

Compare Ipamorelin across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

11US research-market identity

Selank by state

Compare Selank across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

12US research-market identity with a separate FDA-approved medicine record

PT-141 / Bremelanotide by state

Compare PT-141 / Bremelanotide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

13US research-market identity

CJC-1295 no DAC by state

Compare CJC-1295 no DAC across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

14US research-market identity

CJC-1295 DAC by state

Compare CJC-1295 DAC across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

15Investigational clinical program

Retatrutide by state

Compare Retatrutide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

16China-approved medicine and active clinical program

Mazdutide by state

Compare Mazdutide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

17China-approved medicine and active development program

Ecnoglutide by state

Compare Ecnoglutide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

18Investigational clinical program

Enicepatide by state

Compare Enicepatide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

19Investigational clinical program

Eloralintide by state

Compare Eloralintide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

20Investigational clinical program

Cagrilintide by state

Compare Cagrilintide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

21Investigational clinical program

Petrelintide by state

Compare Petrelintide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

22Investigational clinical program

CagriSema by state

Compare CagriSema across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

23Investigational clinical program

MariTide by state

Compare MariTide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

24Investigational clinical program

Survodutide by state

Compare Survodutide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

25Investigational clinical program

VK2735 by state

Compare VK2735 across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

26Investigational clinical program

Pemvidutide by state

Compare Pemvidutide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

27Investigational clinical program

Amycretin / Zenagamtide by state

Compare Amycretin / Zenagamtide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

28US FDA medicine reference

Tirzepatide by state

Compare Tirzepatide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

29FDA-approved US medicine with country-specific status elsewhere

Orforglipron / Foundayo by state

Compare Orforglipron / Foundayo across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

30Product-specific approved medicine records in multiple jurisdictions

Semaglutide by state

Compare Semaglutide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

31FDA-flagged unapproved research-market peptide identity

DSIP / Emideltide by state

Compare DSIP / Emideltide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

32US research-market identity

IGF-1 LR3 by state

Compare IGF-1 LR3 across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

33US research-market identity

Kisspeptin-10 / KP-10 by state

Compare Kisspeptin-10 / KP-10 across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

34US research-market identity separated from SCENESSE

Melanotan I by state

Compare Melanotan I across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

35US research-market non-peptide coenzyme identity

NAD+ by state

Compare NAD+ across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

36US research-market identity with a withdrawn historical medicine record

Sermorelin by state

Compare Sermorelin across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

37No FDA-approved US product; exact foreign prescription products exist

Thymosin Alpha-1 by state

Compare Thymosin Alpha-1 across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

38FDA-approved US medicine with a withdrawn EU application

EGRIFTA WR by state

Compare EGRIFTA WR across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

39Product-specific FDA and EU medicine records

Liraglutide by state

Compare Liraglutide across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

40Product-specific FDA and EU medicine records

SCENESSE by state

Compare SCENESSE across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

41Product-specific FDA-approved US medicine record

VYLEESI by state

Compare VYLEESI across 50 US states. Open the official state pharmacy record and preserve the compound's research, clinical, or medicine identity.

Data dictionary

Definitions travel with the download.

The dictionary keeps identity, state verification, and the publication boundary explicit when rows leave this website.

FieldDefinition
recordIdStable Peptide Local identifier for one compound and US state verification row.
compoundResolved research-market, clinical-pipeline, or approved-medicine identity used by the linked evidence record.
evidenceLaneThe evidence category for the resolved identity. Research listings, clinical programs, and approved medicine records are not interchangeable.
stateDestination US state whose official pharmacy or license record is linked.
searchQueryPlain-language compound and state query represented by this row.
boundedAnswerEditorial routing answer that states what the identity and state record can and cannot establish.
identitySourceUrlPrimary source for the compound, medicine, or clinical-program identity.
stateRecordUrlOfficial state pharmacy, professional, or license verification record.
supportingRecordUrlSecond official safety, supply, pharmacy, or federal record maintained by the state guide.
canonicalAtlasUrlCanonical Peptide Local atlas section for the exact compound and state row.
reviewedDateISO date when the compound-state source route was reviewed.
Use and citation

Link the dataset page or exact atlas section.

Cite this landing page for the complete release. When discussing one compound and state, cite the canonical atlas section stored in that row so the bounded answer and source pair remain visible.

Corrections update the HTML atlas, CSV, and JSON from the same maintained records. A row’s presence does not establish that a substance is legal, illegal, approved, unapproved, safe, unsafe, available, or suitable for an individual.

Compare the global 42-country dataset Browse all state and city guides Submit a correction